Temasek Holdings’s Revolution Medicines RVMD Stock Holding History

Temasek Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,148	Closed	-$251K	–	172
2025 Q4	$251K	Buy	+3,148	New	+$206K	﹤0.01%	139

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Temasek Holdings's RVMD Position: Q1 2026 in Review

Temasek Holdings sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 3,148 shares — an estimated $251K sold.

Temasek Holdings first reported a position in RVMD in Q4 2025 and held it in 1 quarter. The position peaked at $251K in Q4 2025. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Temasek Holdings reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
Temasek Holdings sold 3,148 Revolution Medicines shares in Q1 2026, an estimated $251K.
Temasek Holdings first reported a position in Revolution Medicines in Q4 2025 and held it in 1 quarter.
Temasek Holdings's Revolution Medicines position peaked at $251K in Q4 2025.
514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Temasek Holdings's 13F filing for Q1 2026, filed 12 May 2026.